Form 4: Astera Labs CEO Jitendra Mohan Sells Shares Under 10b5-1 Plan

Astera Labs CEO Jitendra Mohan sold 200,000 shares of common stock on November 21, 2024, at an average price of $103.5347 per share, under a pre-arranged 10b5-1 trading plan.

Summary

• Jitendra Mohan, CEO of Astera Labs, sold a total of 200,000 shares of common stock on November 21, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
• The shares were sold at a weighted average price of $103.5347 per share.
• The sales were made in multiple transactions with prices ranging from $101.6650 to $104.7800.
• The shares were sold from various trusts associated with Mr. Mohan, including a living trust and several estate planning trusts.
• Mr. Mohan disclaims beneficial ownership of the shares held in these trusts, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine SEC Form 4 filing for a pre-planned stock sale by the CEO. It doesn't indicate any positive or negative sentiment about the company's performance, but the market may react to the news of the sale.

Risks

• The sale of a significant number of shares by the CEO could be perceived negatively by the market, potentially impacting the stock price.
• The use of a 10b5-1 plan indicates a pre-planned sale, but the market may still react to the news of the transaction.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein.

Industry Context

Executive stock sales are a common occurrence, especially under pre-arranged 10b5-1 plans. The market typically scrutinizes these transactions for any indication of insider sentiment about the company's future prospects. This sale is not unusual given the use of a 10b5-1 plan.

Comparison to Industry Standards

• Executive stock sales are a common practice across the technology industry, particularly after a company goes public.
• Many executives use 10b5-1 plans to manage their personal finances and avoid accusations of insider trading.
• The size of this sale is not unusual for a CEO of a company of Astera Labs' size and market capitalization.
• Comparable companies such as Marvell Technology and Broadcom also see regular insider sales under similar plans.

Stakeholder Impact

• Shareholders may react to the news of the CEO's stock sale, potentially impacting the stock price.
• The sale does not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Astera Labs, Jitendra Mohan, stock sale, 10b5-1 plan, insider trading, SEC Form 4, executive stock sale